News | March 16, 2012

Canada Clears Boston Scientific’s Blazer Open-Irrigation Ablation Catheter

March 16, 2012 — Boston Scientific Corp. announced Health Canada approval of the Blazer open-irrigated catheter, the company's latest radiofrequency ablation (RFA) catheter designed to treat a variety of arrhythmias such as atrial fibrillation (AF), atrial flutter, ventricular tachycardia and other supraventricular tachycardias. The product will be launched immediately in Canada.

The Blazer open-irrigated catheter integrates Total Tip Cooling design with the high-performance Blazer catheter platform. The Total Tip Cooling design consistently cools the entire tip electrode during radiofrequency (RF) energy delivery, resulting in reduced coagulum at the proximal edges of the tip. This is achieved through both internal cooling and external washing of the tip electrode.

"The excellent cooling profile, coupled with the high performance Blazer platform, makes this catheter an important additional option for performing simple and complex ablations," said Felix Ayala-Parades, M.D., chief electrophysiologist at Sherbrooke University Hospital Centre in Quebec, who performed the first procedure in Canada using the Blazer open-irrigated catheter with Santiago Rivera, M.D. "The tip temperatures were lower than conventional open-irrigated catheters during RF delivery. The catheter handling also allowed for a smooth drag lesion to be created without any gaps in the lesion set and with good contact to ensure adequate lesion creation."

AF is a rapid irregular rhythm affecting the upper chambers of the heart. Patients are most often treated with anti-arrhythmic drugs, which can be associated with adverse side effects. Cardiac ablation with an radiofrequency ablation (RFA) catheter is being used increasingly for patients who cannot tolerate these medications.

"The Health Canada approval and launch of the Blazer open-irrigated catheter in Canada are important milestones in our continued focus on advancing cardiac ablation technology," said Hank Kucheman, CEO of Boston Scientific. "We are committed to expanding our Canadian electrophysiology business and improving outcomes for patients undergoing cardiac ablation procedures."

In the United States, the blazer open-irrigated catheter is an investigational device, limited by applicable law to investigational use only and not available for sale. The product is approved for use in CE mark countries.

For more information: www.bostonscientific.com

Related Content

Thermedical Announces FDA IDE Approval for Clinical Study of Durablate Catheter
News | Ablation Systems | August 02, 2018
Thermedical announced that the U.S. Food and Drug Administration (FDA) has approved its Investigational Device...
Boston Scientific to Acquire Cryterion Medical Inc.
News | Ablation Systems | July 13, 2018
Boston Scientific Corp. recently announced a definitive agreement to acquire Cryterion Medical Inc., a privately-held...
Treating AFib With Ablation Reduces Mortality and Stroke
News | Ablation Systems | July 05, 2018
Using catheter-based ablation instead of medications alone reduces the risks of death and stroke in patients with the...
LuxCath Showcases OmniView Light-Guided Ablation Catheter at HRS 2018
News | Ablation Systems | May 22, 2018
LuxCath LLC showcased the next generation of its proprietary OmniView light-guided catheter ablation system at the 2018...
The Kardium Globe combined mapping and ablation catheter. The device has a distal multi-electrode array consisting of 16 ribs with 122 gold-plated electrodes. Ablation can be done with up to 24 electrodes simultaneously.  #HRS2018

The Kardium Globe combined mapping and ablation catheter. The device has a distal multi-electrode array consisting of 16 ribs with 122 gold-plated electrodes. Ablation can be done with up to 24 electrodes simultaneously. 

News | Ablation Systems | May 21, 2018
May 21, 2018 — Complete pulmonary vein isolation (PVI) was achieved in more than 99 percent of patients in a first-in
CardioFocus Announces Successful Live Case Featuring HeartLight X3 System
News | Ablation Systems | May 17, 2018
Medical device manufacturer CardioFocus Inc. announced a successful live case featuring its HeartLight X3 System during...
Imricor MRI-Guided Cardiac Ablation Study Results to Be Presented at HRS 2018
News | Ablation Systems | May 10, 2018
Results from the clinical study to evaluate Imricor’s Vision-MR Ablation Catheter for the treatment of atrial flutter...
Biosense Webster Launches Carto Vizigo Bi-Directional Guidance Sheath
Technology | Ablation Systems | May 08, 2018
Biosense Webster Inc. announced its Carto Vizigo Bi-directional Guiding Sheath is now available in the United States....
Stereotaxis and Acutus Medical Announce Strategic Collaboration
News | Ablation Systems | May 04, 2018
Stereotaxis and Acutus Medical announced a strategic collaboration to integrate the Stereotaxis Niobe Magnetic...
Medtronic Cryoballoon Shows Positive Results for Patients With Persistent Atrial Fibrillation
News | Ablation Systems | April 12, 2018
Medtronic plc announced one-year results from the CRYO4PERSISTENT AF study of ablation with the Arctic Front Advance...
Overlay Init